Trial
NCT01611662
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Fox Chase Cancer Center
Collaborators
—
Condition
Distal Urethral Cancer
Intervention
gemcitabine hydrochloride
Why stopped
Extreme Toxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-07-29